The roles of the protein tyrosine kinases Pyk2 (also called RAFTK or CAK β) and Syk in the process of functional activation of human myeloid cells were examined. During granulocytic differentiation of HL-60 cells with dimethyl sulfoxide (DMSO), the amounts of Pyk2 and β2 integrin increased, whereas the amount of Syk was abundant before differentiation and did not change during differentiation. When the granulocytic cells were stimulated withN-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP), tyrosine phosphorylation of Pyk2 occurred promptly and subsequent association of Pyk2 with β2 integrin was detected. In contrast, Syk was not tyrosine phosphorylated by fMLP stimulation but constitutively associated with β2 integrin. Stimulation with fMLP also caused the alteration of β2 integrin to an activated form, a finding that was confirmed by the observation of fMLP-induced cell attachment on fibrinogen-coated dishes and inhibition of this attachment by pretreatment with anti-β2 integrin antibody. Cell attachment to fibrinogen caused the enhanced tyrosine phosphorylation of Pyk2 and the initial tyrosine phosphorylation of Syk, which was also inhibited by pretreatment with anti-β2 integrin antibody. In vitro kinase assays revealed that Pyk2 and Syk represented kinase activities to induce tyrosine phosphorylation of several molecules in the anti-β2 integrin immunoprecipitates of the attached cells. These results showed that Pyk2 is involved in the functional activation of granulocytic cells in 2 signaling pathways: an fMLP receptor–mediated “inside-out” signaling pathway that might cause β2 integrin activation and a subsequent β2 integrin–mediated “outside-in” signaling pathway. Syk was activated in relation to cell attachment to fibrinogen as a result of “outside-in” signaling, although it was already associated with β2 integrin before fMLP stimulation.

Several signaling molecules play important roles in the differentiation and execution of unique functions of hematopoietic cells. As a useful model of myeloid differentiation, the HL-60 cell line has been used extensively to study these roles. HL-60 cells can be differentiated with various inducing agents, and HL-60 cells treated this way have the properties of mature myeloid cells.1 TheN-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) receptor belongs to the family of G protein–coupled, heptahelical receptors and is one of the first markers to appear during differentiation of myeloid cells. The ligand, fMLP, mediates effects by means of its receptor, which leads to intracellular signaling followed by cell adhesion and migration.

The well-characterized cell-surface receptors for extracellular matrix proteins on neutrophils belong to the β2 integrin family. Like other integrin families, the β2 integrin family exists as an αβ heterodimer in which a unique α subunit is associated with a common β subunit. Mac-1, LFA-1, and p150/95, which have αM, αL, and αX subunits, respectively, comprise the β2 integrin family.2 They have unique ligands, such as intracellular adhesion molecule-1 and fibrinogen (Fg), and in general, integrin-mediated cell adhesion to its ligands initiates a signaling pathway that mediates protein tyrosine phosphorylation and reorganization of the cytoskeleton.3 

Various protein tyrosine kinases (PTKs) have been reported to be involved in the differentiation and functions of myeloid cells. The roles of Src family PTKs have been well investigated,4-8 but only a few studies of Syk9,10 and Pyk2 have been done.11Pyk2,12 which is also called RAFTK13 or CAK β,14 was isolated as the second member of the FAK family of PTKs. Pyk2 is highly expressed in cells of the central nervous system12-14 and hematopoietic lineages15 and is involved in various signaling pathways, including integrins,15-20 G protein–coupled receptors,12,21-26 various cytokines,27,28stress signaling,29 Jak-mediated signaling,30Fcε receptor I,31 and T-cell receptor.32Syk, a cytoplasmic PTK, is expressed in almost all hematopoietic cells.33,34 Studies have indicated that Syk plays important roles in neutrophils,9,10 monocytic cells,35 platelets,36 mast cells,37 and B cells38 and may be involved in β1,35 β2,9,10 and β336,39 40 integrin-mediated signaling.

We treated HL-60 cells with dimethyl sulfoxide (DMSO) to induce differentiation toward granulocytes. The granulocytic HL-60 cells were then stimulated with fMLP and attached to Fg, one of the ligands for β2 integrin. During this process, we examined expression, tyrosine phosphorylation, and several actions of Pyk2 and Syk.

Reagents and antibodies

Fg was obtained from Yoshitomi Pharmaceutical Co (Osaka, Japan). Fetal-calf serum (FCS) was purchased from Gibco Laboratories (Grand Island, NY). DMSO and fMLP were from Sigma (St Louis, MO). Pertussis toxin (PT) was from Seikagaku Co (Tokyo, Japan), and bovine serum albumin (BSA) was from Intergen Co (Purchase, NY). Polyvinylidene difluoride (PVDF) was from Millipore (Bedford, MA), and protein A–Sepharose beads were from Amersham Pharmacia Biotech Inc (Uppsala, Sweden). Rabbit anti-fMLP receptor polyclonal antibody was previously generated.41 Antiphosphotyrosine monoclonal antibody 4G10 was obtained from Upstate Biotechnology Inc (Lake Placid, NY). Anti-β2 integrin monoclonal antibody IB4 for immunoprecipitation and blocking experiments was from Ancell Co (Bayport, MN). The following antibodies were products of Santa Cruz Biotechnology (Santa Cruz, CA): goat anti-Pyk2 polyclonal antibody for both immunoblotting and immunoprecipitation (SC-1515), rabbit anti-Syk polyclonal antibody for immunoblotting (SC-1077) and immunoprecipitation (SC-929 or SC-573), goat anti-β2 integrin polyclonal antibody for immunoblotting (SC-6623), normal mouse IgG for immunoprecipitation and blocking experiments (SC-2025), and normal goat IgG for immunoprecipitation (SC-2028).

Cell culture and differentiation-induction studies

HL-60 cells were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 2 mmol/L l-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin in 5% carbon dioxide (CO2) humidified air at 37°C. The cells were induced to undergo differentiation to granulocytes by seeding them on dishes at a concentration of 5 × 105 cells/mL in the presence of 1.25% DMSO. Cell differentiation was confirmed morphologically by evaluating cytospin preparations stained with May-Grünwald-Giemsa solution.

Cell stimulation and adhesion assays

Various concentrations of fMLP were added to HL-60 cell suspensions. In some experiments, HL-60 cells were pretreated with either 20 μg/mL mouse anti-β2 integrin monoclonal antibody IB4 for 45 minutes on ice, 20 μg/mL normal mouse IgG for 45 minutes on ice, or 50 ng/mL PT for 4 hours at 37°C in polypropylene tubes.

For adhesion assays, 100-mm culture dishes (3020-100; Iwaki Glass Co, Chiba, Japan) were precoated with Fg (100 μg/mL; 10 mL/dish) overnight at 4°C. Nonspecific binding was blocked with 5% BSA for 1 hour at 37°C. After the BSA was removed, the dishes were washed once gently with PBS and 5 × 106 cells were seeded on the dishes in a 10-mL volume of culture medium. After incubation with 1 μmol/L fMLP for 30 minutes at 37°C, the cells were harvested for cell lysate preparation and cell counting.

Immunoprecipitation procedures

Cells in suspension in polypropylene tubes (5 × 106 cells) were stimulated with fMLP for various times and spun down by centrifugation (10 000g in a flash at 4°C). The incubation medium was removed by aspiration. The pelleted cells were then lysed in 1 mL nonionic lysis buffer (1% Triton X-100, 50 mmol/L Tris–hydrochloric acid [HCl] at pH 7.4, 150 mmol/L sodium chloride (NaCl), 5 mmol/L EDTA, 1 mmol/L sodium vanadate, and 1 mmol/L phenylmethyl sulfonyl fluoride) and kept on ice for 15 minutes. Cells that detached spontaneously or failed to attach after the stimulation were collected and resuspended in polypropylene tubes; these cells were handled in the same manner as cells in suspension. Cells that attached to Fg-coated dishes (5 × 106 cells) on stimulation with fMLP were lysed directly in 1 mL lysis buffer and disrupted by scraping. The lysates were transferred to polypropylene tubes, kept on ice for 15 minutes, and then centrifuged at 15 000g for 10 minutes at 4°C. The supernatants were incubated with 2.5 μg of an antibody for 1 hour at 4°C, and 20 μL protein A–Sepharose diluted in PBS was added. After another hour at 4°C, the immunoprecipitates were washed 3 times with 1 mL lysis buffer. For immunoblotting, the immunoprecipitates were boiled with sodium dodecyl sulfate (SDS) sample buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.001% bromophenol blue, and 62.5 mmol/L Tris-HCl [pH 6.8]) for 3 minutes.

SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting analyses

For day-course studies to detect expression of proteins, whole cell lysates were prepared by boiling with SDS sample buffer for 3 minutes. Whole cell lysates or immunoprecipitates were separated by SDS-PAGE and transferred to PVDF membranes. The membranes were blocked with 5% skim milk in low-salt Tween 20-Tris-buffered saline (T-TBS) (10 mmol/L Tris-HCl [pH 7.4] and 100 mmol/L NaCl containing 0.1% Tween 20) for 30 minutes at 37°C. This was followed by incubation with primary antibodies at either 0.1 μg/mL (for anti-Pyk2, anti-Syk, and anti-β2 integrin antibodies) or 1 μg/mL (for antiphosphotyrosine monoclonal antibody 4G10) in low-salt T-TBS for 1 hour at room temperature. The membranes were then washed and incubated with horseradish peroxidase–conjugated secondary antibodies at 0.5 μg/mL in low-salt T-TBS for 30 minutes at room temperature. After washing with low-salt T-TBS and subsequently with low-salt TBS (10 mmol/L Tris-HCl [pH 7.4] and 100 mmol/L NaCl), enhanced chemiluminescence (ECL) assays were performed to visualize positive bands on x-ray films.

In vitro kinase assays

Immunoprecipitates were washed 3 times with 1 mL lysis buffer and incubated in a 20-μL reaction mixture (50 mmol/L HEPES–sodium hydroxide [pH 8.0], 10 μmol/L sodium vanadate, 50 mmol/L magnesium acetate, 150 mmol/L NaCl, and 10 μmol/L adenosine triphosphate [ATP]) for 30 minutes at 30°C. The reaction was terminated by adding SDS sample buffer and boiling for 3 minutes. The samples were separated by SDS-PAGE, transferred to PVDF membranes, and subjected to immunoblotting analysis with antiphosphotyrosine antibody. The increase in tyrosine phosphorylation was detected by the ECL assay.

Expression of Pyk2 and Syk during granulocytic differentiation of HL-60 cells

HL-60 cells can be induced to differentiate by various agents, including DMSO, which induces these cells to differentiate toward granulocytes.1 We first examined the expression of Pyk2 and Syk during DMSO-induced differentiation of HL-60 cells by using immunoblotting analyses. The expression Pyk2 was low in undifferentiated cells, but an apparent induction occurred on day 1 and reached the peak level in differentiated cells on day 4 (Figure1A). On the other hand, Syk was already abundant in undifferentiated cells, and the expression level did not change during differentiation (Figure 1B). Morphologic evaluation with May-Grünwald-Giemsa staining indicated that about 90% of the cells differentiated toward granulocytes after exposure to DMSO for 4 days. Our immunoblotting analysis did not detect expression of FAK during granulocytic differentiation of HL-60 cells (data not shown).

Fig. 1.

Day-course study of Pyk2 and Syk induction in HL-60 cells in the presence of dimethyl sulfoxide (DMSO).

HL-60 cells were treated with 1.25% DMSO for the indicated days, and whole cell lysates were subjected to immunoblotting analysis with anti-Pyk2 (A) or anti-Syk (B) polyclonal antibody. In each lane, the equivalent amounts of protein (8.5 μg) from whole cell lysates were loaded. In each panel, the positions of molecular markers are shown on the left in kilodaltons. Arrows indicate the position of a Pyk2 (A) or Syk (B) protein band.

Fig. 1.

Day-course study of Pyk2 and Syk induction in HL-60 cells in the presence of dimethyl sulfoxide (DMSO).

HL-60 cells were treated with 1.25% DMSO for the indicated days, and whole cell lysates were subjected to immunoblotting analysis with anti-Pyk2 (A) or anti-Syk (B) polyclonal antibody. In each lane, the equivalent amounts of protein (8.5 μg) from whole cell lysates were loaded. In each panel, the positions of molecular markers are shown on the left in kilodaltons. Arrows indicate the position of a Pyk2 (A) or Syk (B) protein band.

Close modal

Tyrosine phosphorylation of Pyk2 on stimulation with fMLP

Previous studies indicated that the number of fMLP receptors and the ability to respond to fMLP increase in DMSO-differentiated granulocytic HL-60 cells.42,43 These results were confirmed in our experiments by immunoblotting and flow cytometric analyses with anti-fMLP receptor polyclonal antibody (data not shown). We then assessed whether Pyk2 is involved in signaling by means of the fMLP receptor in granulocytic cells. Figure2 shows results of dose-dependence and time-course studies of tyrosine phosphorylation of Pyk2 on stimulation with fMLP. Tyrosine phosphorylation of Pyk2 was detected in the presence of as little as 1 pmol/L fMLP and depended on the amount of fMLP used, with the maximal level reached at an fMLP concentration of 100 nmol/L (Figure 2A). After stimulation with 1 μmol/L fMLP (Figure2B), an increase in tyrosine phosphorylation of Pyk2 was detected at 30 seconds, reached the maximal level at 1 minute, and then gradually returned to the baseline level. Tyrosine phosphorylation was not detected in the immunoprecipitates with normal goat IgG or those with protein A alone (Figure 2B). To confirm that Pyk2 is involved in fMLP receptor–mediated signaling, an effect of PT, which inhibits the signaling of the Gi-protein α subunit by ADP ribosylation in HL-60 cells,44 was examined. Pretreatment with PT for 4 hours, which was sufficient to inhibit the signal mediated by the fMLP receptor,45 inhibited tyrosine phosphorylation of Pyk2 (Figure 2B). These data indicate that Pyk2 is involved in fMLP receptor–mediated signaling.

Fig. 2.

Dose dependence and time-course studies of tyrosine phosphorylation of Pyk2 on stimulation with

N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) in granulocytic cells. HL-60 cells were treated with 1.25% DMSO for 4 days, and the differentiated (granulocytic) cells were then incubated in suspension in polypropylene tubes for 1 minute with the indicated concentrations of fMLP (A) or for the indicated times with 1 μmol/L fMLP (B). Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-Pyk2 polyclonal antibody (A) or with anti-Pyk2 polyclonal antibody, normal goat IgG, or protein A alone (B). In the experiment shown in Figure 2B, an aliquot of cells was pretreated with pertussis toxin (PT) before stimulation with fMLP. Immunoblotting analysis was performed with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with anti-Pyk2 polyclonal antibody (A-B, lower panels). Arrows indicate the position of a Pyk2 protein band (A-B, upper panels).

Fig. 2.

Dose dependence and time-course studies of tyrosine phosphorylation of Pyk2 on stimulation with

N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) in granulocytic cells. HL-60 cells were treated with 1.25% DMSO for 4 days, and the differentiated (granulocytic) cells were then incubated in suspension in polypropylene tubes for 1 minute with the indicated concentrations of fMLP (A) or for the indicated times with 1 μmol/L fMLP (B). Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-Pyk2 polyclonal antibody (A) or with anti-Pyk2 polyclonal antibody, normal goat IgG, or protein A alone (B). In the experiment shown in Figure 2B, an aliquot of cells was pretreated with pertussis toxin (PT) before stimulation with fMLP. Immunoblotting analysis was performed with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with anti-Pyk2 polyclonal antibody (A-B, lower panels). Arrows indicate the position of a Pyk2 protein band (A-B, upper panels).

Close modal

fMLP-induced attachment of granulocytic cells to Fg is mediated by β2 integrin

We observed that stimulation with fMLP promoted attachment of granulocytic cells to Fg-coated dishes. Less than 3% of all cells were attached to the dishes before stimulation, but about 20% of cells became attached after 30 minutes of stimulation. Most of the attached cells had spontaneously detached after about 180 minutes of stimulation. Such attachment was not observed on dishes coated with BSA. Because Fg is one of the ligands for β2 integrin, we examined whether the attachment was mediated by β2 integrin. First, we examined the expression of β2 integrin in granulocytic cells by using immunoblotting analysis. As shown in Figure3A, β2 integrin was induced in the course of granulocytic differentiation of HL-60 cells. Next, we evaluated the effect of pretreatment with mouse anti-β2 integrin monoclonal antibody IB4 on cell attachment to Fg-coated dishes. We observed that IB4 inhibited fMLP-induced cell attachment by about 95%. This inhibition was not observed when the cells were pretreated with normal mouse IgG. These results suggest that fMLP-induced attachment of granulocytic cells to Fg is mediated by β2 integrin.

Fig. 3.

Studies in granulocytic cells attaching to fibrinogen (Fg)-coated dishes on stimulation with fMLP.

(A) Day-course study of β2 integrin induction in HL-60 cells in the presence of DMSO. HL-60 cells were treated with 1.25% DMSO for the indicated days, and whole cell lysates were subjected to immunoblotting analysis with anti-β2 integrin polyclonal antibody. In each lane, the equivalent amounts of protein (8.5 μg) from whole cell lysates were loaded. The positions of molecular markers are shown on the left in kilodaltons. Arrow indicates the position of a β2 integrin protein band. (B-C) Pyk2 and Syk are tyrosine phosphorylated in relation to attachment to Fg. Granulocytic cells were incubated for the indicated times with 1 μmol/L fMLP on Fg-coated dishes (attached/detached) or in suspension in polypropylene tubes (suspension). Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-Pyk2 (B) or anti-Syk (SC-929; C) polyclonal antibody. Immunoblotting analysis was performed with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with the indicated antibodies (B-C, lower panels). Arrows indicate the position of a Pyk2 (B, upper panel) or Syk (C, upper panel) protein band. (D-E) Tyrosine phosphorylation of Pyk2 and Syk in fMLP-stimulated, Fg-attached cells was inhibited by pretreatment of the cells with anti-β2 integrin antibody. Granulocytic cells were incubated for 30 minutes on dishes coated with Fg or bovine serum albumin (BSA) in the presence or absence of 1 μmol/L fMLP. In blocking experiments, some aliquots of cells were pretreated with anti-β2 integrin monoclonal antibody IB4 or normal mouse IgG before stimulation with fMLP. Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-Pyk2 (D) or anti-Syk (SC-573; E) polyclonal antibody. Immunoblotting analysis was performed with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with the indicated antibodies (D-E, lower panels). Arrows indicate the position of a Pyk2 (D, upper panel) or Syk (E, upper panel) protein band.

Fig. 3.

Studies in granulocytic cells attaching to fibrinogen (Fg)-coated dishes on stimulation with fMLP.

(A) Day-course study of β2 integrin induction in HL-60 cells in the presence of DMSO. HL-60 cells were treated with 1.25% DMSO for the indicated days, and whole cell lysates were subjected to immunoblotting analysis with anti-β2 integrin polyclonal antibody. In each lane, the equivalent amounts of protein (8.5 μg) from whole cell lysates were loaded. The positions of molecular markers are shown on the left in kilodaltons. Arrow indicates the position of a β2 integrin protein band. (B-C) Pyk2 and Syk are tyrosine phosphorylated in relation to attachment to Fg. Granulocytic cells were incubated for the indicated times with 1 μmol/L fMLP on Fg-coated dishes (attached/detached) or in suspension in polypropylene tubes (suspension). Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-Pyk2 (B) or anti-Syk (SC-929; C) polyclonal antibody. Immunoblotting analysis was performed with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with the indicated antibodies (B-C, lower panels). Arrows indicate the position of a Pyk2 (B, upper panel) or Syk (C, upper panel) protein band. (D-E) Tyrosine phosphorylation of Pyk2 and Syk in fMLP-stimulated, Fg-attached cells was inhibited by pretreatment of the cells with anti-β2 integrin antibody. Granulocytic cells were incubated for 30 minutes on dishes coated with Fg or bovine serum albumin (BSA) in the presence or absence of 1 μmol/L fMLP. In blocking experiments, some aliquots of cells were pretreated with anti-β2 integrin monoclonal antibody IB4 or normal mouse IgG before stimulation with fMLP. Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-Pyk2 (D) or anti-Syk (SC-573; E) polyclonal antibody. Immunoblotting analysis was performed with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with the indicated antibodies (D-E, lower panels). Arrows indicate the position of a Pyk2 (D, upper panel) or Syk (E, upper panel) protein band.

Close modal

Pyk2 and Syk are tyrosine phosphorylated in relation to cell attachment to Fg

To determine the effect of cell attachment to Fg on cell signaling, tyrosine phosphorylation of Pyk2 and Syk was examined. On stimulation with fMLP, tyrosine phosphorylation of Pyk2 was detected at 1 minute and reduced at 30 minutes in cells in suspension (Figure 2B), but it was augmented at 30 minutes in cells attached to Fg-coated dishes (Figure 3B). Tyrosine phosphorylation was not detected when the cells detached spontaneously after 180 minutes of stimulation (Figure3B). In the studies of Syk, tyrosine phosphorylation was not detected at either 1 minute or 30 minutes in cells in suspension after stimulation with fMLP, but it was detected in cells attached to Fg-coated dishes (Figure 3C).

To evaluate whether tyrosine phosphorylation of Pyk2 and Syk in the fMLP-stimulated cells attached to Fg-coated dishes was mediated by β2 integrin, we examined the effect of pretreatment with anti-β2 integrin monoclonal IB4. As shown in Figure 3D, tyrosine phosphorylation of Pyk2 after 30 minutes of stimulation with fMLP was completely inhibited with IB4 but not with normal mouse IgG in Fg-attached cells. Tyrosine phosphorylation of Pyk2 was not detected in cells on BSA-coated dishes, regardless of whether or not they had been stimulated with fMLP, nor was it detected at 30 minutes in cells on Fg-coated dishes in the absence of stimulation with fMLP (Figure 3D). Similar results were obtained in studies of Syk (Figure 3E). These results suggest that both Pyk2 and Syk participate in a β2 integrin–mediated signaling pathway in granulocytic cells.

Association of Pyk2 and Syk with β2 integrin in fMLP-stimulated granulocytic cells

We conducted coprecipitation studies to examine whether Pyk2 and Syk are associated with β2 integrin in fMLP-stimulated granulocytic cells. Pyk2 was not detected in anti-β2 integrin immunoprecipitates of unstimulated cells or cells stimulated for 1 minute, but it became detectable both in cells kept in suspension and in cells attached to Fg-coated dishes after 30 minutes of stimulation with fMLP (Figure 4A). On the other hand, Syk was constitutively coprecipitated with anti-β2 integrin antibody, regardless of whether or not the cells were stimulated with fMLP or whether they were in suspension or attached (Figure 4B). This association of Pyk2 and Syk was not detected in immunoprecipitates with normal mouse IgG or those with protein A alone (Figure 4A-B). Conversely, β2 integrin was barely detectable in anti-Pyk2 immunoprecipitates of cells kept in suspension (Figure 4A) and cells attached to Fg-coated dishes after 30 minutes of stimulation with fMLP (Figure 5A). In anti-Syk immunoprecipitates, β2 integrin was not detected in similar time-course studies (Figure 4B and 5A).

Fig. 4.

Association of Pyk2 and Syk with β2 integrin in fMLP-stimulated granulocytic cells.

Granulocytic cells were incubated for the indicated times with 1 μmol/L fMLP on Fg-coated dishes (attached) or in suspension in polypropylene tubes (suspension). Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-β2 integrin monoclonal antibody, normal mouse IgG, protein A alone (A-B), anti-Pyk2 polyclonal antibody (A), or anti-Syk (SC-929) polyclonal antibody (B). Immunoblotting analysis was performed with anti-Pyk2 (A) or anti-Syk (B) polyclonal antibody. Each blot was stripped and reprobed with anti-β2 integrin polyclonal antibody (A-B, lower panels). The positions of molecular markers are shown on the left in kilodaltons. Arrows indicate the position of a Pyk2 (A, upper panel), Syk (B, upper panel), or β2 integrin (A-B, lower panels) protein band.

Fig. 4.

Association of Pyk2 and Syk with β2 integrin in fMLP-stimulated granulocytic cells.

Granulocytic cells were incubated for the indicated times with 1 μmol/L fMLP on Fg-coated dishes (attached) or in suspension in polypropylene tubes (suspension). Lysates from the equivalent number of cells (5 × 106 cells) were immunoprecipitated with anti-β2 integrin monoclonal antibody, normal mouse IgG, protein A alone (A-B), anti-Pyk2 polyclonal antibody (A), or anti-Syk (SC-929) polyclonal antibody (B). Immunoblotting analysis was performed with anti-Pyk2 (A) or anti-Syk (B) polyclonal antibody. Each blot was stripped and reprobed with anti-β2 integrin polyclonal antibody (A-B, lower panels). The positions of molecular markers are shown on the left in kilodaltons. Arrows indicate the position of a Pyk2 (A, upper panel), Syk (B, upper panel), or β2 integrin (A-B, lower panels) protein band.

Close modal
Fig. 5.

In vitro kinase assays of anti-β2 integrin, anti-Pyk2, and anti-Syk immunoprecipitates from lysates of fMLP-stimulated granulocytic cells.

(A) Granulocytic cells were incubated for 30 minutes with 1 μmol/L fMLP on Fg-coated dishes (attached) or in suspension in polypropylene tubes (suspension). Anti-β2 integrin, anti-Pyk2, and anti-Syk (SC-573) immunoprecipitates from lysates of the equivalent number of cells (5 × 106 cells) were mixed as indicated and subjected to in vitro kinase assays in the presence or absence of adenosine triphosphate (ATP) and immunoblotting with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with anti-β2 integrin polyclonal antibody. The positions of molecular markers are shown on the left in kilodaltons. Arrows indicate the position of a Pyk2, Syk (upper panel), or β2 integrin (lower panel) protein band. (B-C) Granulocytic cells were incubated for 30 minutes with 1 μmol/L fMLP on Fg-coated dishes (attached) or in suspension in polypropylene tubes (suspension). Anti-Pyk2 (B) and anti-Syk (SC-929; C) immunoprecipitates from lysates of the equivalent number of cells (5 × 106 cells) were subjected to in vitro kinase assays in the presence or absence of ATP and immunoblotting with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with the indicated antibodies (B-C, lower panels). Arrows indicate the position of a Pyk2 (B, upper panel) or Syk (C, upper panel) protein band.

Fig. 5.

In vitro kinase assays of anti-β2 integrin, anti-Pyk2, and anti-Syk immunoprecipitates from lysates of fMLP-stimulated granulocytic cells.

(A) Granulocytic cells were incubated for 30 minutes with 1 μmol/L fMLP on Fg-coated dishes (attached) or in suspension in polypropylene tubes (suspension). Anti-β2 integrin, anti-Pyk2, and anti-Syk (SC-573) immunoprecipitates from lysates of the equivalent number of cells (5 × 106 cells) were mixed as indicated and subjected to in vitro kinase assays in the presence or absence of adenosine triphosphate (ATP) and immunoblotting with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with anti-β2 integrin polyclonal antibody. The positions of molecular markers are shown on the left in kilodaltons. Arrows indicate the position of a Pyk2, Syk (upper panel), or β2 integrin (lower panel) protein band. (B-C) Granulocytic cells were incubated for 30 minutes with 1 μmol/L fMLP on Fg-coated dishes (attached) or in suspension in polypropylene tubes (suspension). Anti-Pyk2 (B) and anti-Syk (SC-929; C) immunoprecipitates from lysates of the equivalent number of cells (5 × 106 cells) were subjected to in vitro kinase assays in the presence or absence of ATP and immunoblotting with antiphosphotyrosine monoclonal antibody 4G10. Each blot was stripped and reprobed with the indicated antibodies (B-C, lower panels). Arrows indicate the position of a Pyk2 (B, upper panel) or Syk (C, upper panel) protein band.

Close modal

To examine whether Pyk2 and Syk are functionally associated with β2 integrin with kinase activities, we performed in vitro kinase assays of anti-β2 integrin, anti-Pyk2, and anti-Syk immunoprecipitates. In the presence of ATP, an increase in tyrosine phosphorylation of several proteins, including 110-kd, 74-kd, 70-kd, and 60-kd protein bands, was detected in anti-β2 integrin immunoprecipitates from the lysates of attached cells, whereas little phosphorylation was observed in cells in suspension (Figure 5A, lanes 1-4). When in vitro kinase assays of anti-Pyk2 and anti-Syk immunoprecipitates were performed, an increase in tyrosine phosphorylation of Pyk2 and Syk was observed in attached cells (Figure 5B-C) but not in suspended cells (Figure 5B and data not shown). These results led us to postulate that Pyk2 and Syk in attached cells exert kinase activities on anti-β2 integrin immunoprecipitates.

Additional kinase assays were performed in the combination of anti-β2 integrin immunoprecipitates and anti-Pyk2 immunoprecipitates or the combination of anti-β2 integrin immunoprecipitates and anti-Syk immunoprecipitates in the presence and absence of ATP. In the presence of ATP, tyrosine phosphorylation of proteins with molecular weights of 110 kd, 90 kd, 74 kd, and 60 kd in the first combination of immunoprecipitates (Figure 5A, lane 8) was quantitatively greater than that in anti-β2 integrin immunoprecipitates (Figure 5A, lane 4) plus that in anti-Pyk2 immunoprecipitates (Figure 5A, lane 6). Tyrosine phosphorylation of proteins with molecular weights of 110 kd, 90 kd, and 60 kd in the second combination of immunoprecipitates (Figure 5A, lane 12) was quantitatively greater than that in anti-β2 integrin immunoprecipitates (Figure 5A, lane 4) plus that in anti-Syk immunoprecipitates (Figure 5A, lane 10). In the absence of ATP, these combinations of immunoprecipitates did not bring about enhanced tyrosine phosphorylation of any of the proteins mentioned above. Because we assume that the additional tyrosine phosphorylation of some proteins associated with β2 integrin in attached cells was mediated by Pyk2 or Syk, it appears that anti-β2 integrin immunoprecipitates of the attached cells contain the substrates of Pyk2 and Syk.

In the current study, we examined the involvement of Pyk2 and Syk in functional activation of HL-60 cells. During granulocytic differentiation, Pyk2 was induced, but its tyrosine phosphorylation was not enhanced (Figure 1A and data not shown). Pyk2 was also induced in the course of 12-o-tetradecanoyl-phorbol-13-acetate (TPA)–induced monocytic differentiation of HL-60 cells, with apparent tyrosine phosphorylation (data not shown). Because it has been demonstrated that Pyk2 is activated when it is tyrosine phosphorylated,20,32 Pyk2 might not be activated during DMSO-induced granulocytic differentiation, but it may be activated during TPA-induced monocytic differentiation of HL-60 cells. Various cytoplasmic PTKs have been found to be related to differentiation of HL-60 cells. Src family PTKs Lyn and Fgr are expressed and tyrosine phosphorylated during retinoic acid–induced granulocytic differentiation, and inhibition of these PTKs by antisense oligodeoxynucleotide caused apoptosis.8 Induction and tyrosine phosphorylation of Fgr was also confirmed in DMSO-differentiated cells.7 Lyn, Fgr, and Fyn were all shown to be activated in the course of monocytic differentiation, and inhibition of these PTKs by PTK inhibitors modulated differentiation.5 6 We found that Syk was constitutively expressed but apparently not tyrosine phosphorylated during DMSO-induced differentiation (Figure 1B and data not shown). Therefore, PTKs involved in differentiation of HL-60 cells might vary in their differentiation inducers and differentiation lineages.

Treatment of HL-60 cells with DMSO resulted in expression of fMLP receptor during granulocytic differentiation (data not shown). To determine whether functional activation of granulocytic cells correlates with activation of Pyk2, we treated the cells with fMLP and detected tyrosine phosphorylation of Pyk2 (Figure 2A-B). This phosphorylation was blocked by PT (Figure 2B), which indicated that Pyk2 is involved in G protein–coupled, receptor-mediated signaling as described in several studies.12 21-26 

G protein–coupled, receptor-mediated signaling leads to activation of some integrins. It was demonstrated that stimulation of neutrophils with fMLP caused alteration of αM β2 integrin from a resting form to an activated form.46 Integrin-ligand binding does not occur in a resting form even if sufficient amounts of integrins are expressed on the surface of the cells. In our study, only a few granulocytic cells attached to Fg-coated dishes before stimulation with fMLP, but cell attachment was obviously promoted after stimulation. Granulocytic cells expressed β2 integrin (Figure 3A), and the cell attachment to Fg was almost completely inhibited by pretreatment with anti-β2 integrin antibody. These findings suggest that β2 integrin is activated as a result of “inside-out” signaling by means of an fMLP receptor–mediated pathway.

Stimulation of granulocytic cells with fMLP caused not only alteration of β2 integrin to an activated form but also tyrosine phosphorylation of Pyk2 (Figure 3B). In addition, association of Pyk2 with β2 integrin was detected after stimulation with fMLP (Figure 4A and 5A). These findings prompted us to postulate that Pyk2 might be involved in the alteration of β2 integrin to an activated form through an “inside-out” signaling process by means of an fMLP receptor–mediated, G protein–coupled pathway. However, there seems to be some dissociation in the time between the initial tyrosine phosphorylation of Pyk2 at 1 minute (Figure 3B) and the association of Pyk2 with β2 integrin at 30 minutes (Figure 4A) after stimulation with fMLP. Previous investigations indicated that the distribution of CAK β is diffuse in cytoplasm and not localized at focal adhesions in a rat fibroblast cell line.47 We speculate on this dissociation as follows. First, Pyk2 close to fMLP receptors becomes tyrosine phosphorylated immediately after stimulation and the following signaling streams run down toward β2 integrin (“inside-out” signaling). Second, Pyk2, not associated with β2 integrin but near it, is affected by this signaling stream and becomes associated with β2 integrin. However, the exact mechanisms of activation of β2 integrin and the roles and interrelations among Pyk2, Syk, and β2 integrin remain to be elucidated.

Cell attachment to ligand-coated dishes often gives rise to “outside-in” signaling through integrins in an activated form. Because we wondered whether Pyk2 is activated through the ligation of β2 integrin, we pretreated granulocytic cells with fMLP and placed the cells on Fg-coated dishes. The secondary signal was generated by cell attachment and enhanced tyrosine phosphorylation of Pyk2 was observed (Figure 3B,D), which was blocked by pretreatment with anti-β2 integrin antibody (Figure 3D). These results indicate that Pyk2 is activated by “outside-in” signaling through β2 integrin. Src family PTKs and Syk are involved in integrin-mediated signaling in neutrophils.9,10,48 We found here that Pyk2 is another PTK involved in β2 integrin–mediated signaling. While our study was in progress, Yan and Novak11 reported that Pyk2 becomes tyrosine phosphorylated in neutrophils. In their system, Pyk2 tyrosine phosphorylation was detected in cells attached to Fg-coated plates after stimulation with fMLP or tumor necrosis factor α and seemed to result from “outside-in” signaling through β2 integrin.

We also showed that Pyk2 and Syk are associated with β2 integrin in a different manner. Pyk2 became associated with β2 integrin after stimulation with fMLP, whereas Syk was associated constitutively with β2 integrin, regardless of stimulation or whether the cells were in suspension or attached (Figure 4A and 4B).

In summary, we speculate that the following molecular events occur. During granulocytic differentiation, fMLP receptor and β2 integrin are induced, and the amount of Pyk2 is increased but neither activated nor associated with β2 integrin. In contrast, Syk is already prepared and associated with β2 integrin but not yet activated. Stimulation with fMLP causes the initial tyrosine phosphorylation of Pyk2 and the subsequent association of Pyk2 with β2 integrin. Alteration of β2 integrin to an activated form also occurs and granulocytic cells can then receive a new stimulation from outside by means of β2 integrin. This stimulation leads to activation of Syk and additionally enhanced activation of Pyk2. Both the Pyk2 and the Syk of Fg-attached cells represented kinase activities (Figure 5B-C) and induced tyrosine phosphorylation of several proteins in anti-β2 integrin immunoprecipitates in vitro (Figure 5A). Taken together, these results indicate that Pyk2 and Syk are both functionally associated with β2 integrin in relation to cell attachment to Fg after stimulation with fMLP but in a different manner. Thus, various signals that are receptor-mediated or integrin-mediated and coupled by tyrosine kinases may be involved in the functional activation of granulocytic cells.

We thank Dr Momoyo Asahi (Fukui Prefectural University, Fukui, Japan) for discussions about fMLP signaling.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.

1
Collins
 
SJ
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression.
Blood.
70
1987
1233
1244
2
Sanchez-Madrid
 
F
Nagy
 
JA
Robbins
 
E
Simon
 
P
Springer
 
TA
A human leukocyte differentiation antigen family with distinct α-subunits and a common β subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150, 95 molecule.
J Exp Med.
158
1983
1785
1803
3
Clark
 
EA
Brugge
 
JS
Integrins and signal transduction pathways: the road taken.
Science.
268
1995
233
239
4
Yan
 
SR
Fumagalli
 
L
Dusi
 
S
Berton
 
G
Tumor necrosis factor triggers redistribution to a Triton X-100-insoluble, cytoskeletal fraction of β2 integrins, NADPH oxidase components, tyrosine phosphorylated proteins, and the protein tyrosine kinase p58fgr in human neutrophils adherent to fibrinogen.
J Leukoc Biol.
58
1995
595
606
5
Katagiri
 
K
Katagiri
 
T
Koyama
 
Y
Morikawa
 
M
Yamamoto
 
T
Yoshida
 
T
Expression of src family genes during monocytic differentiation of HL-60 cells.
J Immunol.
146
1991
701
707
6
Katagiri
 
K
Katagiri
 
T
Kajiyama
 
K
Uehara
 
Y
Yamamoto
 
T
Yoshida
 
T
Modulation of monocytic differentiation of HL-60 cells by inhibitors of protein tyrosine kinases.
Cell Immunol.
140
1992
282
294
7
Miyazaki
 
Y
Katamine
 
S
Kohno
 
T
Moriuchi
 
R
Miyamoto
 
T
Tomonaga
 
M
fgr proto-oncogene is expressed during terminal granulocytic differentiation of human promyelocytic HL60 cells.
Exp Hematol.
21
1993
366
371
8
Katagiri
 
K
Yokoyama
 
KK
Yamamoto
 
T
Omura
 
S
Irie
 
S
Katagiri
 
T
Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells.
J Biol Chem.
271
1996
11557
11562
9
Yan
 
SR
Huang
 
M
Berton
 
G
Signaling by adhesion in human neutrophils. Activation of the p72syk tyrosine kinase and formation of protein complexes containing p72syk and Src family kinases in neutrophils spreading over fibrinogen.
J Immunol.
158
1997
1902
1910
10
Fernandez
 
R
Suchard
 
SJ
Syk activation is required for spreading and H2O2 release in adherent human neutrophils.
J Immunol.
160
1998
5154
5162
11
Yan
 
SR
Novak
 
MJ
β2 integrin-dependent phosphorylation of protein-tyrosine kinase Pyk2 stimulated by tumor necrosis factor α and fMLP in human neutrophils adherent to fibrinogen.
FEBS Lett.
451
1999
33
38
12
Lev
 
S
Moreno
 
H
Martinez
 
R
et al
Protein tyrosine kinase Pyk2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions.
Nature.
376
1995
737
745
13
Avraham
 
S
London
 
R
Fu
 
Y
et al
Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain.
J Biol Chem.
270
1995
27742
27751
14
Sasaki
 
H
Nagura
 
K
Ishino
 
M
Tobioka
 
H
Kotani
 
K
Sasaki
 
T
Cloning and characterization of cell adhesion kinase β, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily.
J Biol Chem.
270
1995
21206
21219
15
Salgia
 
R
Avraham
 
S
Pisick
 
E
et al
The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells.
J Biol Chem.
271
1996
31222
31226
16
Astier
 
A
Avraham
 
H
Manie
 
SN
et al
The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after β1-integrin stimulation in B cells and binds to p130Cas.
J Biol Chem.
272
1997
228
232
17
Ma
 
EA
Lou
 
O
Berg
 
NN
Ostergaard
 
HL
Cytotoxic T lymphocytes express a β3 integrin which can induce the phosphorylation of focal adhesion kinase and the related Pyk-2.
Eur J Immunol.
27
1997
329
335
18
Gismondi
 
A
Bisogno
 
L
Mainiero
 
F
et al
Proline-rich tyrosine kinase-2 activation by β1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells.
J Immunol.
159
1997
4729
4736
19
Sieg
 
DJ
Ilic
 
D
Jones
 
KC
Damsky
 
CH
Hunter
 
T
Schlaepfer
 
DD
Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK− cell migration.
EMBO J.
17
1998
5933
5947
20
Li
 
J
Avraham
 
H
Rogers
 
RA
Raja
 
S
Avraham
 
S
Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes.
Blood.
88
1996
417
428
21
Yu
 
H
Li
 
X
Marchetto
 
GS
et al
Activation of a novel calcium-dependent protein-tyrosine kinase: correlation with c-Jun N-terminal kinase but mitogen-activated protein kinase activation.
J Biol Chem.
271
1996
29993
29998
22
Jeschke
 
M
Standke
 
GJR
Susa
 
M
Fluoroaluminate induces activation and association of Src and Pyk2 tyrosine kinases in osteoblastic MC3T3–E1 cells.
J Biol Chem.
273
1998
11354
11361
23
Roca
 
GJD
Biesen
 
T
Daaka
 
Y
Luttrell
 
DK
Luttrell
 
LM
Lefkowitz
 
RJ
Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors: convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase.
J Biol Chem.
272
1997
19125
19132
24
Felsh
 
JS
Cachero
 
TG
Peralta
 
EG
Activation of protein tyrosine kinase Pyk2 by the m1 muscarinic acetylcholine receptor.
Proc Natl Acad Sci U S A.
95
1998
5051
5056
25
Raja
 
S
Avraham
 
S
Avraham
 
H
Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism.
J Biol Chem.
272
1997
10941
10947
26
Brinson
 
AE
Harding
 
T
Diliberto
 
PA
et al
Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor: dependence on calcium and the actin cytoskeleton.
J Biol Chem.
273
1998
1711
1718
27
Hatch
 
WC
Ganju
 
RK
Hiregowdara
 
D
Avraham
 
S
Groopman
 
JE
The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulation factor signaling in monocyte-macrophages.
Blood.
91
1998
3967
3973
28
Liu
 
Z
Ganju
 
RK
Wang
 
J
et al
Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.
J Clin Invest.
99
1997
1798
1804
29
Tokiwa
 
G
Dikic
 
I
Lev
 
S
Schlessinger
 
J
Activation of Pyk2 by stress signals and coupling with JNK signaling pathway.
Science.
273
1996
792
794
30
Miyazaki
 
T
Takaoka
 
A
Nogueira
 
L
et al
Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway.
Genes Dev.
12
1998
770
775
31
Okazaki
 
H
Zhang
 
J
Hamawy
 
MM
Siraganian
 
RP
Activation of protein-tyrosine kinase Pyk2 is downstream of Syk in FcεRI signaling.
J Biol Chem.
272
1997
32443
32447
32
Ganju
 
RK
Hatch
 
WC
Avraham
 
H
et al
RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes.
J Exp Med.
185
1997
1055
1063
33
Taniguchi
 
T
Kobayashi
 
T
Kondo
 
J
et al
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis.
J Biol Chem.
266
1991
15790
15796
34
Yanagi
 
S
Kurosaki
 
T
Yamamura
 
H
The structure and function of nonreceptor tyrosine kinase p72syk expressed in hematopoietic cells.
Cell Signal.
7
1995
185
193
35
Lin
 
TH
Rosales
 
C
Mondal
 
K
Bolen
 
JB
Haskill
 
S
Juliano
 
RL
Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells: a possible signaling role for the Syk tyrosine kinase.
J Biol Chem.
270
1995
16189
16197
36
Clark
 
EA
Shattil
 
SJ
Ginsberg
 
MH
Bolen
 
J
Brugge
 
JS
Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin αIIbβ3.
J Biol Chem.
269
1994
28859
28864
37
Hirasawa
 
N
Scharenber
 
A
Yamamura
 
H
Beaven
 
MA
Kinet
 
J
A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by FcεR1 is not shared by a G protein-coupled receptor.
J Biol Chem.
270
1995
10960
10967
38
Kurosaki
 
T
Takata
 
M
Yamanashi
 
Y
et al
Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling.
J Exp Med.
179
1994
1725
1729
39
Tohyama
 
Y
Yanagi
 
S
Sada
 
K
Yamamura
 
H
Translocation of p72syk to the cytoskeleton in thrombin-stimulated platelets.
J Biol Chem.
269
1994
32796
32799
40
Tohyama
 
Y
Tohyama
 
K
Tsubokawa
 
M
Asahi
 
M
Yoshida
 
Y
Yamamura
 
H
Outside-in signaling of soluble and solid-phase fibrinogen through integrin αIIbβ3 is different and cooperative with each other in a megakaryoblastic leukemia cell line, CMK.
Blood.
92
1998
1277
1286
41
Lala
 
A
Sojar
 
HT
Nardin
 
ED
Expression and purification of recombinant human N-formyl-L-leucyl-L-phenylalanine (FMLP) receptor: generation of polyclonal antibody against fMLP receptor.
Biochem Pharmacol.
54
1997
381
390
42
Niedel
 
J
Kahane
 
I
Lachman
 
L
Cuatrecasas
 
P
A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor.
Proc Natl Acad Sci U S A.
77
1980
1000
1004
43
Naccache
 
PH
Molski
 
TFP
Spinelli
 
B
Borgeat
 
P
Abboud
 
CN
Development of calcium and secretary responses in the human promyelocytic leukemia cell line HL60.
J Cell Physiol.
119
1984
241
246
44
Klinker
 
JF
Wenzel-Seifert
 
K
Seifert
 
R
G-protein coupled receptors in HL-60 human leukemia cells.
Gen Pharmacol.
27
1996
33
54
45
Goldman
 
DW
Chang
 
FH
Gifford
 
LA
Goetzl
 
EJ
Bourne
 
HR
Pertussis toxin inhibition of chemotactic factor induced calcium mobilization and function in human polymorphonuclear leukocytes.
J Exp Med.
162
1985
145
156
46
Jones
 
SL
Knaus
 
UG
Bokoch
 
GM
Brown
 
EJ
Two signaling mechanisms for activation of αMβ2 avidity in polymorphonuclear neutrophils.
J Biol Chem.
273
1998
10556
10566
47
Matsumiya
 
M
Sasaki
 
H
Aoto
 
H
et al
Cell adhesion kinase β forms a complex with a new member Hic-5, of proteins localized at focal adhesions.
J Biol Chem.
273
1998
10031014
48
Lowell
 
CA
Fumagalli
 
L
Berton
 
G
Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions.
J Cell Biol.
133
1996
895
910

Author notes

Kaoru Tohyama, Department of Laboratory Medicine and Clinical Sciences, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan: e-mail: ktohyama@kuhp.kyoto-u.ac.jp.

Sign in via your Institution